Baxter International stock turns on guidance and buybacks
Published on 08/22/2026 at 15:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Baxter International Inc. (US0673431090) is trading against a $2.96 billion second quarter and FY 2026 EPS guidance of $1.95 to $2.15, with the company valued at $13.63 billion in the latest market snapshot.
The most recent report showed revenue up 5.3% year over year, while earnings came in at $0.56 a share versus $0.37 expected. That mix matters because it ties the share reaction to both execution and a guidance range that still leaves room for debate.
Guidance and valuation
Analyst views also point to a firmer setup than earlier in the summer. One recent summary put the consensus price target at $22.45, while another narrative valued the shares at $28.73 versus a last close of $26.34.
The comparison is concrete: the latest quarter's $0.56 EPS exceeded consensus by $0.19, and revenue topped estimates by $160 million. For investors, that gap is the cleanest proof point in the current Baxter story.
Balance sheet pressure
The same market note said Baxter carried a debt-to-equity ratio of 1.39, a quick ratio of 1.32, and a current ratio of 1.95. Those figures frame the stock around cash discipline as much as around growth.
Institutional activity has also stayed active, with one filing showing a new 43,244-share position valued at $922,000 and broader ownership at 90.19% of the float. That kind of ownership mix often keeps attention on operating delivery.
Renal care core
Baxter's renal care lineup includes hemodialysis and peritoneal dialysis systems, water treatment equipment, dialyzers, bloodlines, and catheters. The segment remains central because it links the company to recurring hospital and dialysis-center demand.
More on Baxter International stock can be found in its portfolio of medication delivery, acute therapies, pharmacy automation, surgical care, and biotechnology-based solutions.
Shares and setup
The stock opened at $26.37 in the latest market read, with a 52-week range of $15.73 to $30.00 and a 200-day moving average of $20.36. That places Baxter between its yearly extremes but still below the top end of the range.
Market profile
Company: Baxter International Inc.
ISIN: US0673431090
Ticker: BAX
Exchange: NYSE
Market cap: $13.63 billion
Sector / Industry: Health Care / Medical Instruments & Supplies
More on Baxter International stock
As of August 22, 2026, Baxter International stock opened at $26.37, compared with a 52-week high of $30.00 and a 52-week low of $15.73.
